Trending Online CME

Optimizing the Management of Advanced Cervical Cancer With Checkpoint Inhibitor Therapy

NEW ACTIVITY | 1.0 CME/CE
This case-based online activity features a discussion between leading clinical investigators, Ramez Eskander, MD and Bradley Monk, MD, FACS, FACOG, as they explore the management of advanced cervical cancer with checkpoint inhibitor therapy.

Current Trends and Future Directions in Targeted Therapies for Advanced Renal Cell Carcinoma

NEW ACTIVITY | 1.0 CME | ILNA Points
Watch this CME-certified discussion with Brian I. Rini, MD, FACP from Cleveland Clinic Lerner College of Medicine as he discusses emerging data on targeted therapies for the treatment of patients with advanced RCC.

Defining Personalized Care Plans in Metastatic Castration-Resistant Prostate Cancer

1.0 CME/CE | ILNA Points

Watch this CME/CE-certified discussion with Tanya Dorff, MD from the Keck School of Medicine as she discusses progress in our understanding of predictive/prognostic markers in advanced prostate cancer as well as optimizing treatment sequencing and response assessment.

Selecting Optimal Therapeutic Strategies for Patients With Differentiated and Medullary Thyroid Cancer

1.0 CME | ILNA Points

In this case-based activity, leading clinical investigator Jochen Lorch, MD, MS from Dana-Farber Cancer Institute will share insights into evidence-based personalized care planning for patients with differentiated and medullary thyroid cancer.

Appraisal of Recent Progress in Metastatic Castration-Resistant Prostate Cancer: Current Trends and Future Directions

1.0 CME | ILNA Points

In this case-based activity, leading clinical investigator Oliver Sartor, MD examines recent developments and best practices in treatment selection and supportive care planning for patients with metastatic CRPC.

CME Live Meetings

Challenges and Opportunities in Castration-Resistant Prostate Cancer

1.0 CME/CE/CPE | VA/DoD Meeting Series

This live activity will bring a leading clinical investigator to your VA/DoD medical center to discuss emerging data on treatment selection, resistance, and response in CRPC. Schedule a meeting at your institution today!

Current Challenges and New Opportunities in Follicular Lymphoma

1.0 CME/CE | Visiting Faculty Meeting Series

This live activity will bring a leading clinical investigator to your cancer center to discuss emerging data in treatment selection and supportive care for patients with previously untreated and relapsed/refractory FL. Enroll your institution today!

New Directions in the Management of Recurrent Ovarian Cancer: Focus on PARP Inhibitors

1.0 CME | Visiting Faculty Meeting Series

This activity will bring a leading clinical investigator to your cancer center to discuss emerging data on PARP inhibitors that can rationally inform the management of ovarian cancer. Enroll your institution today!

Castration-Resistant Prostate Cancer: Implementing New Data and Evolving Standards

1.0 CME | Satellite Symposium
This satellite symposium will discuss risk stratification, combination and sequential treatment strategies, and drug resistance in metastatic and nonmetastic castration-resistant prostate cancer at the SGSU 2019 Kimbrough Urologic Seminar.
© Copyright 2018 i3 Health. All rights reserved.